Cancer Supportive Care Drugs Market is Expected to Register a Considerable Growth by 2028

The cancer supportive care drugs market was estimated at US$ 20.9 billion in 2021 and is expected to grow at a CAGR of 2.04% during 2022-2028 to reach US$ ~21.40 billion in 2028.

The development of biosimilars and the approval and use of targeted treatments, which have fewer side effects than conventional chemotherapy drugs, are anticipated to restrain market growth. The ageing population, increased cancer incidence, and widespread use of chemotherapy in low- and middle-income areas are all driving forces in the market. Cancer treatment has been significantly impacted by the global COVID-19 pandemic.